Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
0.3731
+0.0076 (2.08%)
At close: Aug 7, 2025, 4:00 PM
0.3728
-0.0003 (-0.08%)
Pre-market: Aug 8, 2025, 5:37 AM EDT
Theseus Pharmaceuticals Employees
Veru Inc. had 210 employees as of September 30, 2024. The number of employees increased by 21 or 11.11% compared to the previous year.
Employees
210
Change (1Y)
21
Growth (1Y)
11.11%
Revenue / Employee
$80,412
Profits / Employee
-$173,078
Market Cap
54.69M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 210 | 21 | 11.11% |
Sep 30, 2023 | 189 | -44 | -18.88% |
Sep 30, 2022 | 233 | -19 | -7.54% |
Sep 30, 2021 | 252 | -87 | -25.66% |
Sep 30, 2020 | 339 | -47 | -12.18% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VERU News
- 1 day ago - Veru Announces Reverse Stock Split - GlobeNewsWire
- 16 days ago - Veru to Participate in the 2025 BTIG Virtual Biotech Conference - GlobeNewsWire
- 2 months ago - Veru to Participate in the Virtual BTIG Obesity Health Forum - GlobeNewsWire
- 2 months ago - Veru's Enobosarm Shows Muscle In Wegovy Combo Trial - Benzinga
- 2 months ago - Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone - GlobeNewsWire
- 2 months ago - Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom - Seeking Alpha
- 3 months ago - Veru Inc. (VERU) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Accesswire